Lirilumab (Anti-KIR)

製品コード：A2419        

印刷

Lirilumab (Anti-KIR) is a  fully human monoclonal antibody against killer-cell immunoglobulin-like receptors (KIR), with potential antineoplastic activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research. MW: 150 kD.

製品説明

CAS No. 1000676-41-4
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Isotype Human IgG4SP
Source CHO
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions

人間や獣医の診断であるか治療的な使用のためにでない。